Phone: 866.839.4840 | Fax: 732.905.7893

Archive for June, 2012

Posted on: June 4th, 2012 by Martek Pharmacal

June 2012
Akrimax Pharmaceuticals is currently manufacturing Phentermine Hydrochloride 15mg and 30mg tablets.  Their products are orally disintegrating tablets (ODT) and can be taken with or without water.   Akrimax is marketing their Phentermine as “Brand” items under the name Suprenza.  Please contact us for additional product and price information.
The FDA has delayed its decision to approve the weight loss drug, Qnexa.  The target date has been pushed back to July 17 to consider a new drug safety plan submitted by the manufacturer, Vivus.   Previously the agency was scheduled to make a decision by April 17.  Vivus stated the three-month extension is standard when companies submit additional risk management information for a drug.
We are now completely out of the Bontril 35mg tablets and 105mg capsules.  If you were using these products, please contact us to discuss the generic alternatives.